| MolName | (E)-4-[[1-(4-chlorophenyl)-2,5-dioxopyrrolidin-3-yl]-(2-phenylethyl)amino]-4-oxobut-2-enoic acid |
| MolecularFormula | C22H19N2O5Cl |
| Smiles | OC(/C=C/C(N(CCc1ccccc1)C(CC(N1c(cc2)ccc2Cl)=O)C1=O)=O)=O |
| InChI | InChI=1S/C22H19ClN2O5/c23-16-6-8-17(9-7-16)25-20(27)14-18(22(25)30)24(19(26)10-11-21(28)29)13-12-15-4-2-1-3-5-15/h1-11,18H,12-14H2,(H,28,29)/t18-/m1/s1 |
| InChIK | NUFHZMLAVMQAAW-GOSISDBHSA-N |
| TotalMolweight | 426.855 |
| Molweight | 426.855 |
| MonoisotopicMass | 426.09825 |
| CLogP | 2.2775 |
| CLogS | -3.773 |
| H Acceptors | 7 |
| H Donors | 1 |
| TotalSurfaceArea | 313.17 |
| Relative PSA | 0.23106 |
| PolarSurfaceArea | 94.99 |
| Druglikeness | 4.93 |
| Mutagenic | none |
| Tumorigenic | none |
| Reproductive Effective | none |
| Irritant | high |
| Nasty Functions | |
| Shape Index | 0.5 |
| Fragments | 1 |
| Non HAtoms | 30 |
| NonCHAtoms | 8 |
| Electronegative Atoms | 8 |
| StereoCenters | 1 |
| Rotatable Bond | 7 |
| Rings Closures | 3 |
| Small Rings | 3 |
| Aromatic Rings | 2 |
| Aromatic Atoms | 12 |
| Sp3Atoms | 5 |
| Symmetricatoms | 4 |
| Amides | 2 |
| AcidicOxygens | 1 |
| StereoCon | racemate |
Click to Load Molecule:
1 - (E)-4-[[1-(4-chlorophenyl)-2,5-dioxopyrrolidin-3-yl]-(2-phenylethyl)amino]-4-oxobut-2-enoic acid | 2 - (E)-4-[[1-(4-chlorophenyl)-2,5-dioxopyrrolidin-3-yl]-(2-phenylethyl)amino]-4-oxobut-2-enoic acid